Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab.
Saved in:
| Title: | Long-term clinical outcome of patients with metastatic melanoma and initial stable disease during anti-PD-1 checkpoint inhibitor immunotherapy with pembrolizumab. |
|---|---|
| Authors: | Noringriis, Inge Mansfield1 (AUTHOR), Donia, Marco1 (AUTHOR), Madsen, Kasper1 (AUTHOR), Schmidt, Henrik2 (AUTHOR), Haslund, Charlotte Aaquist3 (AUTHOR), Bastholt, Lars4 (AUTHOR), Svane, Inge Marie1 (AUTHOR) inge.marie.svane@regionh.dk, Ellebaek, Eva1 (AUTHOR) eva.ellebaek.steensgaard@regionh.dk |
| Source: | British Journal of Cancer. Aug2025, Vol. 133 Issue 3, p337-345. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/s41416-025-03048-8 |
